# ArriVent BioPharma, Inc.: Form 8-K, filed Jun 22, 2026

- Company: [ArriVent BioPharma, Inc.](/companies/avbp.md) (CIK 1868279)
- Form: 8-K
- Filed: 2026-06-22
- Accepted by EDGAR: Jun 22, 2026, 16:01 ET
- Period: 2026-06-18
- Accession: 0001104659-26-076352
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1868279/000110465926076352/tm2618466d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1868279/000110465926076352/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1868279/000110465926076352/tm2618466d1_8k.htm

Filed Jun 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-076352. Last ingested by Listed: Nov 5, 2026, 13:51 ET. No prices; not investment advice.